Schedule 13G ownership disclosure

SIGILON THERAPEUTICS INC

Security class unavailable · CUSIP: 82657L107

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
28.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-045171
Form type
SC 13G
Filer
Flagship Ventures Fund V, L.P.
CIK
CIK 1627639
Filed
Feb 16, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub